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Abstract
Extracellular superoxide dismutase (EC-SOD) is an isoform of SOD normally found both intra- and extra-cellularly and
accounting for most SOD activity in blood vessels. Here we explored the role of EC-SOD in protecting against brain damage
induced by chronic hypoxia. EC-SOD Transgenic mice, were exposed to hypoxia (FiO2.1%) for 10 days (H-KI) and compared
to transgenic animals housed in room air (RA-KI), wild type animals exposed to hypoxia (H-WT or wild type mice housed in
room air (RA-WT). Overall brain metabolism evaluated by positron emission tomography (PET) showed that H-WT mice had
significantly higher uptake of 18FDG in the brain particularly the hippocampus, hypothalamus, and cerebellum. H-KI mice
had comparable uptake to the RA-KI and RA-WT groups. To investigate the functional state of the hippocampus,
electrophysiological techniques in ex vivo hippocampal slices were performed and showed that H-KI had normal synaptic
plasticity, whereas H-WT were severely affected. Markers of oxidative stress, GFAP, IBA1, MIF, and pAMPK showed similar
values in the H-KI and RA-WT groups, but were significantly increased in the H-WT group. Caspase-3 assay and
histopathological studies showed significant apoptosis/cell damage in the H-WT group, but no significant difference in the
H-KI group compared to the RA groups. The data suggest that EC-SOD has potential prophylactic and therapeutic roles in
diseases with compromised brain oxygenation.
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Introduction
Hypoxia plays a crucial role in acute and chronic CNS
pathologies. Exposure to hypoxia results in a significant increase in
reactive oxygen species (ROS), including superoxide, which is
produced mainly in the mitochondria [1–4]. ROS leads to
impaired neurogenesis, hippocampal atrophy, altered transcrip-
tion factor regulation, and protein expression [5–6].
Excess ROS, particularly superoxide, can oxidize nitric oxide
(NO) to reactive nitrogen species (RNS) including peroxynitrite
[7–8]. This process leads to decreased NO bioavailability,
accumulation of toxic products including NO2 [9–10]. Both
ROS and RNS oxidize macromolecules (DNA, proteins, and
lipids), culminating in CNS neurodegeneration [11]. Oxidative
stress also activates glial-mediated inflammation [12]. HIF-1 alpha
rapidly accumulates during the onset of hypoxia, remaining at this
level for 14 days before gradually declining to normal by 21 days
despite continuous hypoxia [13–14]. A pathophysiological role for
HIF-1alpha has been established for hypoxic ischemic diseases
[15].
Neurons are particularly susceptible to ROS/RNS injury [16],
but may adapt to hypoxia by activating neuroprotective signaling
cascades e.g. MAPK, ERK1/2, and protein kinase-B [17–18]
increasing glycolytic energy metabolism and free-radical defenses
[19], down-regulating oxidative-stress genes, and up-regulating
antioxidant genes [20].
Overexpression of mitochondrial SOD2 inhibits post-ischemic
mitogen-activated protein kinase and decreases DNA fragmenta-
tion following ischemia/reperfusion [21–25]. The outcome from
middle cerebral artery occlusion is worse in SOD2 deficient
animals [26]. A neuroprotective role for SOD mimetics has been
demonstrated in an ex-vivo brain model [27].
EC-SOD is expressed in the brain at a lower level than other
SODs [28], but provides defense against ROS produced by
membrane-bound NAD(P)H oxidase [29]. EC-SOD is predomi-
nantly localized in neurons of hippocampus, lateral nucleus of the
thalamus and hypothalamus. Both EC-SOD and neuronal NO
synthase are similarly distributed in the striatum and cortex [30].
EC-SOD is the only extracellular SOD isoform and the major
SOD activity in blood vessels, which leads to increase NO
bioavailability [31].
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Mice, engineered to overexpress EC-SOD, have increased
tolerance to both focal and global cerebral ischemia [32–34], while
EC-SOD knock-outs exhibit enhanced damage [35]. These data
implicate an important role for EC-SOD ischemia/reperfusion
pathologies, and suggest a therapeutic role for SOD mimetics.
Previously, we showed that EC-SOD offers significant protec-
tion against oxidative stress-induced lung injury [36–37] and brain
injury induced by hyperoxia [38]. In this study, we hypothesized
that EC-SOD overexpression offers protection to the brain
exposed to chronic hypoxia. This could be of importance to
many diseases with compromised brain oxygenation.
Material and Methods
All experiments involving animals were reviewed and approved
by the Institutional Animal Care and Use Committee of the
Feinstein Institute for Medical Research, and performed in
accordance with the guidelines set by the Institute for Laboratory
Animal Research. Adult C57BL6 mice, (8–10 week old), either
wild type (WT) or transgenic animals (KI) generated by
microinjecting nuclei of fertilized oocytes from (C57Bl/6#C3H),
with the cDNA of human EC-SOD containing a Beta-actin
promoter [29], were housed in a pathogen-free environment,
under standard light and dark cycles, with free access to food and
water. An animal hypoxia chamber system (BioSpherix, Lacona,
NY) was used for the in vivo studies. With this system, a constant
10% normobaric hypoxia was achieved for up to 10 days in our
study. Animals were divided into four groups (10/group) and
housed for 10 days as follows: Group A: WT adult mice housed in
room air (RA-WT). Group B: KI adult mice housed in room air
(RA-KI). Group C: WT adult mice housed in hypoxia (H-WT).
Group D: KI adult mice housed in hypoxia (H-KI). After 10 days,
the animals were assessed using PET, and were then euthanized
and brain tissues harvested.
Functional studies
1- PET scanning. Brains were scanned after exposure to
hypoxia for 10 days and compared to matched room air controls.
Scanning was performed using 18FDG, which was injected
intraperitoneally at a dose of 400 Micro Curie per mouse. After
45 min., the mice were assessed at the PET scan center located
within the Feinstein Institute for Medical Research.
2- Hippocampal Electrophysiology. Mice were anesthe-
tized with isoflurane in a closed container, then immediately
decapitated. The brain was quickly extracted into ice-cold (,2C)
artificial cerebral spinal fluid (ACSF) that contained: NaCl
(126 mM), NaHCO3 (26 mM), glucose (10 mM), KCl (2.5 mM),
CaCl2 (2.4 mM), MgCl2 (1.3 mM), and NaH2PO4 (1.2 mM), and
was continuously gassed with carbogen (95% O2, 5% CO2).
Kynurenic acid (1 mM), which is a non-specific blocker of
excitatory amino acid receptors, was added to the ACSF solution
during the dissection and slicing procedures. The brain was
bisected and both hemispheres were mounted onto a block with
ethyl cyanoacrylate glue. Transverse hippocampal slices (400 mm
thick) were prepared using a Leica VT1200 vibratome. Slices were
incubated in ACSF gassed with carbogenfor 35 min at 35C
followed by 120 min at 24C. One slice at a time was transferred to
a recording chamber, continuously perfused with ACSF gassed
with carbogen at 30C, for electrophysiological studies. Field
excitatory postsynaptic potentials (fEPSP) were recorded with
borosilicate glass electrodes (2–3 M ohmns tip resistance) placed in
the stratum radiatum, of the CA1, at the midpoint between two
bipolar stimulating electrodes (Frederick Haer & Co, Bowdoin-
ham, ME) that activated Schaeffer collateral/commissural axons.
This setup allowed for the recording of two independent pathways
(test and control) in the same slice. The initial slope of the fEPSP
was used as a measure of the postsynaptic response. fEPSP
responses were amplified (AM Systems 1800), digitized at 10 kHz,
and analyzed online with custom software (written with AxoBasic,
Axon Instruments, Union City, CA). For obtaining input-output
(I-O) functions, the stimulation was reduced to a value at which no
fEPSP was evoked. The stimulation was then increased incremen-
tally to evoke larger fEPSPs. This was done until the appearance of
a population spike, generated by CA1 pyramidal cells, which
defined the final point of the I-O function. For plasticity
experiments, a stable baseline was obtained for at least 15 min.
The baseline intensity was set to obtain a fEPSP slope that was
half-maximal, as determined by I-O curves. Long-term potenti-
ation (LTP) was induced by high-frequency stimulation (HFS),
which consisted of either tetanus (100 Hz for 1 sec) or theta burst
stimulation (TBS, 10 trains of 4 pulses at 100 Hz, with 200 ms
between trains). We calculated LTP from 30 responses at 40–
45 min post-HFS. For all LTP experiments, picrotoxin (100
microM) was added to block GABAA receptors [39].
Molecular studies
1- Superoxide dismutase (SOD) assays. After PET scan-
ning, all animals were euthanized. Brains were isolated and
immediately frozen. SOD activity was assessed in brain homog-
enates using an Oxiselect superoxide dismutase activity assay kit
(Cell Biolabs, Dan Diego, CA). This assay utilizes a xanthine/
xanthine oxidase system to generate superoxide anions, which
reduce a chromagen to a water soluble formazan dye. The activity
of SOD in the brain tissue homogenate was determined as the
inhibition of chromagen reduction. Quantitative assays of SOD1,
SOD2,and hSOD3 were done by western blot and compared to
B-Actin protein concentration.
2- Glutathione assay. For the determination of the reduced
glutathione (GSH) and oxidized glutathione (GSSG) ratio, the
brain was homogenized and the homogenates were treated with a
mixture of metaphosphoric acid, EDTA, and NaCl. After
centrifugation, aliquots were taken for neutralization with
disodium hydrogen phosphate followed by addition of DTNB.
Reduced and oxidized glutathione were measured in brain tissue
homogenates by reaction with DTNB (5,59-dithiobis-2-nitroben-
zoic acid) using a Glutathione Assay Kit (Calbiochem, Gibbson-
town, NJ), following the manufacturer’s instructions. Reduced
glutathione (GSH) was determined after reaction with DTNB in a
spectrophotometer at 412 nm. For the determination of oxidized
glutathione (GSSG), the autoxidation of GSH was stopped by
addition of N-ethylmaleimide. After addition of sodium hydroxide,
GSSG was modified using o-phthalaldehyde. GSSG was deter-
mined at a spectrofluorometer (excitation: 350 nm, emission:
420 nm) using GSSG standards for quantification [40].
3- Western Blotting. Frozen brain tissues were crushed and
homogenized, and protein extraction was carried out using a Total
Protein Extraction Kit (BioChain Institute, Inc. Hayward, CA).
Protein concentration was estimated using the Modified Lowry
Protein Assay (Thermo Fisher Scientific, Rockford, IL, USA).
Samples were prepared for SDS-PAGE in Laemmli Sample Buffer
(Bio-rad, Hercules, CA, USA). Standard SDS-PAGE techniques
were followed as previously described [38]. Running buffer and
Transfer buffer were purchased from Bio-Rad (Hercules, CA,
USA). Briefly electrophoresis was performed using a Mini Format
1-D Electrophoresis Systems (Bio-Rad, Hercules, CA, USA) on
10–12% ready tris-HCl gels (Bio-rad, Hercules, CA, USA). After
electrophoresis, proteins were transferred to a PVDF membrane
using a Wet/Tank Blotting System (Bio-rad, Hercules, CA, USA).
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Figure 1. SOD activity ratio in adult mouse brain groups (WT and KI), after exposure to hypoxia (10% for 10 days) in comparison
with the RA control groups (WT and KI). Data are mean of 10 animals per group 6 SEM. *P,0.05 versus the KI hypoxia and WT hypoxia groups
(Fig. 1A). Quantitative Western blot for SDO1, SOD2 & hSDO3 (presented as a ratio for B-Actin), in adult mouse brain groups (WT and KI) after
exposure to hypoxia (10% for 10 days) in comparison with the RA control groups (WT and KI). Data are mean of 56 SEM animals per group. *P,0.05
HI-KI vs. RA groups and WT hypoxia groups; and H-WT vs. RA groups (Fig. 1B).
doi:10.1371/journal.pone.0108168.g001
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Membranes were briefly washed and immediately incubated with
respective primary antibody in 5% BSA with PBST overnight
(primary antibody was diluted according to the manufacturer’s
recommendation). The next day, after washing, the membranes
were incubated with HRP-conjugated secondary antibodies for
40–60 min (diluted according to the manufacturer’s recommen-
dation). After incubation with secondary antibody, the membranes
were washed and then processed using Amersham ECL detection
systems (GE healthcare, Piscataway, NJ USA). The membranes
were then immediately exposed to 8610 Fuji X-Ray Film.
Developed films were quantified using Quantity One 1-D Analysis
Software on a GS-800 Calibrated Densitometer. The density of
each band was evaluated and presented as a ratio in comparison to
Actin band density. The following primary antibodies were used to
detect the following markers: GFAP (Cell Signaling Technology,
Danvers, MA, USA), Iba-1 (Wako Chemicals USA, Richmond,
VA, USA), MIF (Abcam, Cambridge, MA, USA), pAMPK
(Beauchamp et al., 2004), (Cell Signaling Technology, Danver,
MA), pAMPK (Cell Signaling Technology, Danver, MA, USA),
and anti-Actin protein (as an internal control) (Gene Script,
Olathe, KS, USA). Horseradish Peroxidase (HRP)-Conjugated
Goat Anti-Rabbit IgG conjugate was used for detection of rabbit
primary antibodies (Bio-Rad, Hercules, CA, USA). Goat anti-
mouse HRP conjugates were used for detection of mouse primary
antibodies (Southern Biotech, Birmingham, AL, USA).
Structural studies
1- Caspase 3 activity assay. Caspase 3 activity was
measured using the Caspase-3 Colorimetric Assay (R&D Systems,
Minneapolis, MN, USA). The assay was carried out following the
manufacturer’s instructions and described previously [41]. Brain
tissue samples were homogenized in buffer containing 10 mM
HEPES (pH 7.4), 42 mM KCl, 5 mM MgCl2, 1 mM dithiothre-
itol, 1% Triton X-100, 0.5% CHAPS, 1 mM phenyl methyl
sulfonyl fluoride, and 1 micro gm/mL leupeptin, and centrifuged
at 12,000 g for 10 minutes at 4uC. A 10-mL aliquot of the lysate
was incubated in a flat bottom 96 well plate, 50 microL tissue
lysates were incubated with 50 microL 2x reaction buffer followed
by 5 microL of caspase-3 colorimetric substrate (DEVD-pNA), and
incubated at 37C for 2 hrs. The fluorescence was measured at
room temperature at the excitation wavelength of 360 nm, and
emission was measured at 460 nm with the use of a multiplate
fluorescence reader (Biotek Instruments). Protein concentration
was measured with a Pierce kit (Pierce Biotechnology, Rockford,
IL, USA). Ac-AMC was used to obtain a standard curve. Enzyme
activity was calculated as picomoles per minute per mg of protein.
2- Histopathological studies. Brain tissue was fixed in 10%
neutral buffered formalin for 24 hours, processed, embedded in
paraffin wax, and subsequently cut into 4 micron thick sections.
Following de-paraffinization, hematoxylin and eosin (H&E)
staining was performed according to standard protocols. Standard
sections were made of the hippocampus, cerebellum, and
cerebrum in each group of animals.
Figure 2. Brain PET scan with an FDG standardized uptake value, showing a cross and longitudinal sections of brain uptake.
doi:10.1371/journal.pone.0108168.g002
EC-SOD and Chronic Brain Hypoxia
PLOS ONE | www.plosone.org 4 September 2014 | Volume 9 | Issue 9 | e108168
Statistical analyses
Values are presented as mean 6 SEM. Comparisons among
groups were made using analysis of variance (ANOVA) or
unpaired Student’s t test, as appropriate. P value ,0.05 was used
as the cutoff for significant findings.
Results
SOD activity and quantity
Among KI adults, we found SOD activity in brain tissue was
statistically significantly higher (x2) than WT adults after exposure
to hypoxia (P,0.05) (Figure 1A). To find out which SOD is
contributing to the increase in SOD activity, quantitative measure
of SOD1, SOD2 and hSOD3 in all brain tissue was done. Our
study showed that increased SOD activity after exposure to
hypoxia in group KI, is mainly due to increase of both SOD2 and
hSOD3 which are increased significantly in KI hypoxic group
compared to RA groups and WT hypoxic group (P,0.05)
(Fig. 1B). The Beta-actin promoter driving the expression of the
human EC-SOD transgene did not lead to augmented expression
in KI mice in response to hypoxia, but this significant augmen-
tation in hEC-SOD protein expression in our model could by
induced by other stimuli like NO [42].
Functional studies demonstrate neuronal protection in
H-KI mice
PET scans showed that there was a higher uptake of 18FDG in
hypoxic groups compared to the normoxic groups, and the
difference was statistically significant (P,0.05). Interestingly, the
18FDG uptake of H-KI brains was lower than H-WT brains in
areas sensitive to hypoxia, such as the hippocampus, hypothala-
mus, thalamus, and medulla (Figure 2 & Table 1), revealing that
H-WT brains were maximally activated in their metabolism.
Table 1. PET scan data showing FDG in adult mice brain groups (WT and KI) after exposure to hypoxia (10% for 10 days), in
comparison with the RA control groups (RA-WT and RA-KI).
Region RA-WT RA-KI H-WT H-KI *P value
AcbCore/Shell 0.442 0.436 1.494 0.940 0.003
CaudatePutamen 0.513 0.494 1.727 1.056 0.006
CentralCanal-PAG 0.401 0.396 1.480 0.961 0.004
Pons 0.159 0.156 0.635 0.382 0.004
Septum 0.385 0.372 1.423 0.893 0.001
Medulla 0.220 0.207 0.842 0.490 0.005
Whole Brain 0.349 0.326 1.237 0.754 0.001
Amygdala 0.222 0.209 0.741 0.447 0.002
Cortex-Auditory 0.488 0.450 1.599 0.937 0.002
Cingulate-Ctx 0.607 0.540 2.019 1.223 0.001
Entorhinal-Ctx 0.206 0.195 0.675 0.409 0.003
Frontal-Ctx 0.459 0.355 1.641 0.993 0.002
Insular-Ctx 0.346 0.318 1.218 0.731 0.001
MedialPrefrontal-Ctx 0.558 0.525 1.827 1.130 0.003
Motor-Ctx 0.543 0.447 1.958 1.152 0.001
OrbitoFrontal-Ctx 0.500 0.440 1.802 1.123 0.000
Parietal-Ctx 0.532 0.456 1.809 1.113 0.001
Retrosplenial-Ctx 0.548 0.486 1.871 1.113 0.002
Somatosensory-Ctx 0.539 0.480 1.881 1.132 0.002
Visual-Ctx 0.520 0.471 1.752 1.049 0.001
Hippocampus-Dorsal 0.412 0.381 1.426 0.921 0.003
Hippocampus-Ventral 0.340 0.316 1.277 0.813 0.002
Hypothalamus 0.183 0.177 0.687 0.411 0.001
Olfactory-Ctx 0.248 0.235 0.907 0.581 0.000
pituitary 0.001 0.001 0.005 0.003 0.004
Superior Colliculi 0.519 0.467 1.712 1.061 0.000
Midbrain 0.457 0.441 1.605 0.966 0.003
VTA 0.304 0.310 1.121 0.677 0.005
Cerebellar Grey 0.323 0.321 1.151 0.699 0.008
Cerebellar White 0.392 0.361 1.387 0.850 0.005
InferiorColliculi 0.546 0.497 1.803 1.065 0.001
Thalamus 0.521 0.468 1.776 1.087 0.001
Data are mean 6 SEM of 10 animals per group. *P,0.05 versus the KI hypoxia and WT hypoxia groups.
doi:10.1371/journal.pone.0108168.t001
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We next evaluated electrophysiological studies in ex vivo
hippocampal measured with input-output curves for the fEPSPs
of CA1 synapses, elicited by stimulation of the CA3 afferents. The
data show that synaptic transmission was greatly affected in both
hypoxic groups when compared to the RA-WT slices (P,0.05).
However, the H-KI group showed significantly stronger transmis-
sion than the H-WT group (P,0.05), (Figure 3), suggesting that
the H-WT synapses were the most affected by hypoxia. Notably,
the H-KI group displayed normal long-term synaptic plasticity
(LTP), because their LTP measured at 45-min post-tetanic
stimulation was similar to the RA-WT group. Conversely, the
H-WT slices showed complete absence of LTP (Figure 3).
Molecular studies showed attenuation of inflammatory
and neural cell damage markers in H-KI mice
GSH/GSSG ratio represents the consumption of reduced
glutathione due to accumulation of ROS. GSH/GSSG was
significantly lower in the H-WT group compared to the H-KI
group (P,0.05). Moreover, there was no difference between the
H-KI and RA-KI groups. (Figure 4).
Next, we performed quantitative western blot analysis for
inflammatory markers expressed as a ratio of protein density of
each marker to Actin protein band density. GFAP expression
indicates astrocytes inflammation and damage; it was statistically
significantly higher in the H-WT group compared to the H-KI
group (P,0.05). There was no difference between the H-KI and
RA-KI groups. Iba1 expression, which indicates microglial cells
inflammation/damage was statistically significantly higher in the
H-WT group compared to the H-KI group (P,0.05). There was
no difference between the H-KI and RA-KI groups. MIF
expression as an index of systemic inflammation was statistically
significantly higher in the H-WT group compared to the H-KI
group (P,0.05). There was no difference between the H-KI and
RA-KI groups. pAMPK expression as a metabolic marker, was
statistically significantly higher in the H-WT group compared to
the H-KI group (P,0.05). pACC was also significantly higher in
the H-WT group compared to the other three groups, which
indicates both increased amounts of pAMPK and pAMPK activity
(Table 2).
Structural studies showed reduction of cell death and
inflammation in H-KI mice
Caspase 3 activity, as a direct evidence of apoptosis, was
significantly higher in both hypoxic groups compared to the
normoxic groups (P,0.05). However, there was a significantly
lower caspase 3 activity in the H-KI group compared to the H-
WT group (P,0.05) (Figure 5).
Sections of the cerebrum, cerebellum or the hippocampus
showed no damage (in RA groups) to minimal damage (in H-KI
group). However, in the H-WT group, damage was seen in each of
the cerebrum, cerebellum, and the hippocampus. Damage was
very prominent in the cortical neurons of the grey matter, purkinje
neurons in the cerebellum, and the neurons in the dendate gyrus of
the hippocampus, which showed ischemic changes (red neuron
degeneration) (Figures 6A, B & C).
Discussion
Adverse impacts of chronic or intermittent hypoxia on
development, behavior, and academic achievement have been
reported in many well-designed and controlled studies in children,
as well as in a variety of studies in adults [43]. Hypoxia, either
chronic or intermittent, has been shown to increase oxidative stress
and the generation of increased superoxide anion in the brain [44–
Figure 3. Hippocampal electrophysiological studies showing
protected synaptic transmission and plasticity in H-KI slices,
when compared to H-WT mice. (A) Representative fEPSPs of CA1
synapses at increasing stimulation strengths. (B) Input-output curves for
the different groups. The slope of the fEPSPs in CA1 synapses is plotted
against the stimulation intensity to the CA3 afferents. (C) Plot showing
the slope of the fEPSPs, with a tetanus applied at 5 min (upward arrow)
to induce LTP. (D) Bar graphs showing protection of synaptic
transmission (left graph) and plasticity (right graph) in the H-KI group,
when compared to the H-WT group. Notably, LTP in the H-KI group is
completely normal.
doi:10.1371/journal.pone.0108168.g003
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45]. In this study, we showed that overexpression of EC-SOD
preserved the excitatory postsynaptic potential and hippocampal
neural plasticity after exposure to hypoxia compared to wild type
adult mice. We also have shown a clear correlation between
overexpression of EC-SOD and decreased brain damage induced
by chronic hypoxia exposure as indicated by functional, molec-
ular, and structural studies.
The protection against hypoxia-induced brain damage, offered
by overexpression of EC-SOD, could be explained by different
mechanisms. The oxidative stress produced by hypoxic insults
leads to decreased SOD activity, increasing malondialdehyde
(MDA), and lactic acid levels [46]. Inactivation of EC-SOD
activity has also been shown to be associated with 100-fold
elevation in hypoxia-induced Epo gene expression, compared with
wild-type controls. In our KI animal model, there was marked
significant increase of SOD activity when compared to WT
hypoxia. It is known that human EC-SOD exists as an active and
inactive isoform [47]. The marked significant increase of SOD
activity in presence of little difference in the amount of EC-SOD
among transgenic hypoxic animal vs. wild hypoxic animal, could
be explained based on the possibility of having more active EC-
SOD in the hypoxic transgenic mice and less inactive EC-SOD
and this accounts for the marked change in total SOD activity.
When EC-SOD was overexpressed, a significant reduction in Epo
gene induction has been shown in hypoxia both in vitro and in
vivo [48]. The inhibitory effect of EC-SOD on hypoxia-induced
Epo expression could be due to partial stabilization of HIF-1alpha.
It is known that hypoxia generated superoxide radicals are
required for induction of HIF-1alpha activity and other down-
stream target genes [49–50]. In KI animals with overexpression of
EC-SOD, dismutation of free radicals will be increased compared
to the WT group. This leads to decreased levels of ROS including
superoxide, which plays a major role in stabilization and activation
of HIF-1alpha [51]. The resulted reduction of ROS concentration
will decrease HIF-1alpha activation. Modulation of transcription
Figure 4. Reduced glutathione/oxidized ratio (GSH / GSSG) in adult mouse brain groups (WT and KI) after exposure to hypoxia
(10% for 10 days) in comparison with the RA control groups (WT and KI). Data are mean of 10 animals per group 6 SEM. *P,0.05 versus
the KI hypoxia and WT hypoxia groups.
doi:10.1371/journal.pone.0108168.g004
Table 2. Quantitative Assessment of Western blot for molecular markers including: GFAP, IBA1, MIF, pAMPK, and pACC in adult
mouse brain groups (WT and KI) after exposure to hypoxia (10% for 10 days), in comparison with the RA control groups (WT and
KI).
Markers RA-WT RA-KI H-WT H-KI
GFAP 0.79260.04 0.79660.03 1.42660.08 0.81260.08*
Iba1 0.16060.01 0.16260.02 0.19460.01 0.17860.01*
MIF 0.66260.07 0.69960.07 0.93560.09 0.71460.02*
pAMPK 0.43060.12 0.42060.15 1.37860.34 0.76560.19*
pACC 0.27660.01 0.26760.01 0.55160.04 0.36960.01*
Data are mean of 106 SEM animals per group. *P,0.05 versus the KI hypoxia and WT hypoxia groups.
* P,0.05 (H WT vs. H KI).
doi:10.1371/journal.pone.0108168.t002
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factor HIF-1 alpha and its important gene target VEGF by the
antioxidant enzyme EC-SOD was confirmed in other studies [52].
Another important mechanism, which has a great implication in
explaining our findings, concerns nitric oxide (NO). NO inhibits
hypoxia-inducible transcription of the Epo gene through suppres-
sion of HIF-1alpha expression, DNA binding activity, and
transcriptional activity [53–54]. Under hypoxic conditions, there
is a rapid accumulation of superoxide which rapidly reacts with
NO to form peroxynitrite and other toxic metabolities [55–56]. In
KI animals with enhanced expression of EC-SOD, superoxide is
dismutated by EC-SOD to form H2O2. Decreased levels of
superoxide would lead to increased physiologic NO concentrations
and its bioavailability [57–58]. A physiological consequence of this
is that EC-SOD influences blood vessel tone by maintaining the
biological activity of NO [35].
With overexpression of EC-SOD and dismutation of superox-
ide, hydrogen peroxide accumulation is important. Many studies
have handled this logical assumption by analyzing H2O2 in
different settings. Most of the studies conclude that more SOD
does not mean more H2O2 [59]. The formation of H2O2 due to
dismutation of superoxide, is limited by the amount of superoxide,
not by the rate it is converted to H2O2. Accumulation of
superoxide leads to the oxidation of NO with the formation of
peroxynitrite. In this situation more H2O2 is very unlikely to be
toxic since this would amount to substituting a very mild cytotoxin
(H2O2) for a very potent one (peroxynitrite). H2O2 downregulates
GRK2 expression which plays a key role in G protein-coupled
receptor (GPCR) signaling modulation, and its expression levels
are decreased after brain hypoxia/ischemia. Therefore, pharma-
cological agents effective in the treatment of brain ischaemia/
hypoxia should obtain an increase in the level of H2O2 by blocking
GPx, preferably associated to an increased enzymatic activity of
SOD and CAT. In the study conducted by [60], either GPx or
CAT inhibition enhanced H2O2 toxicity in rat hippocampal slices,
confirming the importance of the integrity of glial antioxidant
network [61].
It has been shown that hypoxic exposure (chronic or
intermittent) leads to a variety of neurological consequences
which can include psychomotor impairment, learning and spatial
memory impairment, and in extreme cases, memory retrieval
impairment. Reaction time, total number and performance of
tasks decrease significantly in hypoxic conditions, and changes in
visual sensitivity, attention span, arithmetic and decision making
abilities have also been noted [6],[62–64]. Imaging studies using
PET imaging of H-KI and H-WT mice, showed a marked and
significant reduction in FDG uptake in all scanned brain regions
including brain regions sensitive to hypoxia mainly the hippo-
campus, hypothalamus, thalamus, and medulla (Table 1). Increas-
es in 18FDG uptake observed in specific brain regions of hypoxic
animals, is generally thought to represent an increase demand in
glucose metabolism from those intact cells remaining within the
affected area. In fact, these alterations suggest a temporal effect of
hypoxia on glucose metabolism. Finally, measurements made at
times further from the initial insult may demonstrate not only
greater, more widespread changes, but also marked decreases in
18FDG uptake as a consequence of significant cell loss.
Electrophysiological studies showed that the H-KI group had a
significantly stronger transmission than the H-WT group (P,
0.05), suggesting that the H-WT synapses were the most affected
by hypoxia. Additionally, the H-KI group displayed normal long-
term synaptic plasticity, with their LTP, measured at 45-min post-
tetanic stimulation, similar to the RA-WT group. Conversely, the
H-WT slices showed complete absence of LTP. Our evaluation of
the hippocampal CA1-SC circuit does not include any connectiv-
Figure 5. Activated caspase 3 ELISA in adult mouse brain groups (WT and KI), after exposure to hypoxia (10% for 10 days) in
comparison with the RA control group (WT and KI). Data are mean of 10 animals per group 6 SEM. *P,0.05 versus the KI hypoxia and WT
hypoxia groups.
doi:10.1371/journal.pone.0108168.g005
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ity data, such as synaptic counts, though we believe that this data
might add to our understanding of the role of EC-SOD in
hippocampal function. This finding could explain the deteriora-
tion of both learning and memory in WT mice after exposure to
hypoxia and also shows the protective effect of overexpression of
EC-SOD in the KI mice group (Fig. 2). We believe that it is the
first time that the protective effect of overexpression of EC-SOD
has been reported in this setting.
Hypoxic exposure results in a significant increase in pro-
inflammatory cytokines including MIF [2]. In neonatal rats with
hypoxia-ischemia brain damage, there was a marked increase in
the expression of MIF in the brain [64]. In the murine brain, MIF
transcripts and protein are mainly present in the cortex,
hippocampus, and pituitary gland [65]. In our study there was a
significantly marked reduction of MIF expression in brain tissue of
H-KI mice compared to the H-WT group (Table 2). This finding
supports the anti-inflammatory function of EC-SOD, which could
be explained by down regulation of HIF-1alpha and inactivation
of NF-KB [55,66]. In our previous studies, we showed that
overexpression of EC-SOD inhibits activation of NF-KB induced
by increased ROS in our in vitro model [57],[67]. Decreased
brain cell inflammation/damage induced by hypoxia was signif-
icantly prominent by the significant decrease in the studied
inflammatory markers including GFAP, IBA1, and MIF.
In summary, overexpression of EC-SOD and increased its
activity has a significant protective effect against chronic hypoxia-
induced brain damage. A therapeutic approach that increases EC-
SOD protein accumulation, either by overexpression or a
therapeutic supplement, could be used prophylactically in patients
with long term pathological conditions and chronic disease such as
COPD, pulmonary hypertension, sleep disordered breathing and
sickle cell disease, all of which are associated with compromised
brain oxygenation. A similar approach may also be useful in
situations such as hypoxic ischemic insult of newborn, sickle cell
disease, stroke or drowning, all of which can lead to impairment of
brain function, including learning and spatial memory impairment
and psychomotor impairment. Additionally, such a regime could
be used as a protective measure for individuals who are operating
at the limits of human tolerance and facing relevant operational
stressors such as hypoxia, a significant physiological threat at
altitude.
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Figure 6. Brain histopathological studies of the control RA and KI hypoxia groups. (A) high-power (40X) H&E staining of cortical brains
with normal structure for both the control RA and KI hypoxia groups, while the WT hypoxia group showed injury damage (id). (B) H&E, high-power
(60X) view of neurons from the dentate gyrus in the hippocampus with no ischemic damage in both the control and KI hypoxia groups, while the WT
hypoxia group showed injury damage (id). (C) H&E, high-power (40X) view of Purkinje cells and granular cells in the cerebellum with no ischemic
damage in both the control and KI hypoxia groups, while WT hypoxia group showed injury damage (id).
doi:10.1371/journal.pone.0108168.g006
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